Annovis Bio Consensus Price Target Lowered by 16.67% to $10.71

Published 15 Sep 2026, 07:22 UTC. Updated 15 Sep 2026, 08:35 UTC.

The average one-year price target for Annovis Bio (NYSE:ANVS) has been revised to $10.71 / share as of September 11, 2026. This is a decrease of 16.67% from the prior estimate of $12.85 dated August 25, 2026. These figures represent aggregate analyst targets and do not constitute

Directly affected

ANVS Annovis Bio
Named in this report.

Indirectly affected

BTCZ T-Rex 2X Inverse Bitcoin Daily Target ETF
GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
DOGG FT VEST DJIA DOGS 10 TARGET INCOME ETF
GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
FGSI FT VEST GROWTH STRENGTH & TARGET INCOME ETF
GA selected FGSI as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
ITDB ISHARES LIFEPATH TARGET DATE 2030 ETF
GA selected ITDB as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
ITDC ISHARES LIFEPATH TARGET DATE 2035 ETF USD
GA selected ITDC as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.
ITDE ISHARES LIFEPATH TARGET DATE 2045 ETF USD
GA selected ITDE as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article.

Price reaction, T-5 to T+3

Ticker	T-5	T-3	T-1	T0	T+1	T+2	T+3
ANVS	—	—	—	—	—	—	—
BTCZ	—	—	—	—	—	—	—
DOGG	—	—	—	—	—	—	—
FGSI	—	—	—	—	—	—	—
ITDB	—	—	—	—	—	—	—
ITDC	—	—	—	—	—	—	—
ITDE	—	—	—	—	—	—	—

The average one-year price target for Annovis Bio (NYSE:ANVS) has been revised to $10.71 / share as of September 11, 2026. This is a decrease of 16.67% from the prior estimate of $12.85 dated August 25, 2026. These figures represent aggreg…

Source: Nasdaq Markets

Price since this story was published: Annovis Bio (ANVS)

Since the first closing price after “Annovis Bio Consensus Price Target Lowered by 16.67% to $10.71,” Annovis Bio (ANVS) is -8.84%. The S&P 500 fund (SPY) is +1.66% over the same days, a -10.50% difference versus the market.

ANVS

SPY

Who gains and who loses around Annovis Bio (ANVS)

Companies carried with this story

ANVS Annovis Bio
For “Annovis Bio Consensus Price Target Lowered by 16.67% to $10.71,” Annovis Bio (ANVS) is linked, with no stored direction, high confidence. Reason on file: The reported development directly names ANNOVIS BIO in the headline; GA resolved that company to ANVS
BTCZ T-Rex 2X Inverse Bitcoin Daily Target ETF
T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ) is linked, with no stored direction, medium confidence in the 15 Sep 2026 story “Annovis Bio Consensus Price Target Lowered by 16.67% to $10.71.” Reason on file: GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
DOGG Ft Vest Djia Dogs 10 Target Income Etf
For “Annovis Bio Consensus Price Target Lowered by 16.67% to $10.71,” Ft Vest Djia Dogs 10 Target Income Etf (DOGG) is linked, with no stored direction, medium confidence. Reason on file: GA selected DOGG as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
FGSI Ft Vest Growth Strength & Target Income Etf
Ft Vest Growth Strength & Target Income Etf (FGSI) is linked, with no stored direction, medium confidence in the 15 Sep 2026 story “Annovis Bio Consensus Price Target Lowered by 16.67% to $10.71.” Reason on file: GA selected FGSI as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
ITDB Ishares Lifepath Target Date 2030 Etf
In “Annovis Bio Consensus Price Target Lowered by 16.67% to $10.71,” Ishares Lifepath Target Date 2030 Etf (ITDB) is linked, with no stored direction, medium confidence. Reason on file: GA selected ITDB as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
ITDC Ishares Lifepath Target Date 2035 Etf Usd
In “Annovis Bio Consensus Price Target Lowered by 16.67% to $10.71,” Ishares Lifepath Target Date 2035 Etf Usd (ITDC) is linked, with no stored direction, medium confidence. Reason on file: GA selected ITDC as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article
ITDE Ishares Lifepath Target Date 2045 Etf Usd
In “Annovis Bio Consensus Price Target Lowered by 16.67% to $10.71,” Ishares Lifepath Target Date 2045 Etf Usd (ITDE) is linked, with no stored direction, medium confidence. Reason on file: GA selected ITDE as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article

Annovis Bio (ANVS)

Annovis Bio (ANVS) is the company in “Annovis Bio Consensus Price Target Lowered by 16.67% to $10.71,” the 15 Sep 2026 this story story.

Annovis Bio (ANVS) is on the page because The reported development directly names ANNOVIS BIO in the headline; GA resolved that company to ANVS

T-Rex 2X Inverse Bitcoin Daily Target ETF (BTCZ) is here too. Its reason reads: GA selected BTCZ as a RELATED security because its canonical security name directly matches this event's themes: target. This is an explainable DERIVED market relationship, not a claim that the security was named in the source article

Price levels for Annovis Bio (ANVS)

ANVS traded between 0.95 and 1.43 across 20 sessions. The latest close on file is 0.98. BTCZ traded between 2.69 and 3.21 across 20 sessions. The latest close on file is 3.06. DOGG traded between 20.68 and 22.21 across 20 sessions. The latest close on file is 21.99.

What the saved facts support for Annovis Bio (ANVS)

46 out of 100

“Annovis Bio Consensus Price Target Lowered by 16.67% to $10.71” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.